Replies to post #91387 on Mohacsy's Safe Portfolio Member Forum

[n4807g]

I missed it (really wasn't following the company), but I think there's a lot of smoke and no fire here. Looks like a momentum run on a tiny biotech. All it took was a PR on a phase II trial, but as they say the devil is in the details. Be very careful with this one.

See DD's post here: https://investorshub.advfn.com/boards/replies.aspx?msg=160054938

As I've noted in the past, if you want to follow biotechs on IH DD's board is about the best to read, many very capable people with biotech and medical backgrounds post, and they do great research work.